Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
MVM Partners, LLC | 0001947083 | Feb-03-2023 | 10 percent owner |
MVM Partners LLP | 0001893459 | Nov-04-2021 | 10 percent owner |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by MDxHealth SA
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
424B5 | Document | Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001213900-24-081940 (33 Act) Size: KB |
Sep-26-2024 | 241326100 |
424B5 | Document | Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001213900-24-081808 (33 Act) Size: KB |
Sep-25-2024 | 241324220 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-071457 (34 Act) Size: KB |
Aug-21-2024 | 241228873 |
EFFECT | Document | Acc-no: 9999999995-24-002118 (33 Act) Size: KB | Jul-10-2024 | 241110970 |
CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001213900-24-059813 ( Act) Size: KB |
Jul-08-2024 | |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-059810 (34 Act) Size: KB |
Jul-08-2024 | 241104698 |
F-3/A | Document | Amendment to Registration statement for specified transactions by certain foreign private issuers Acc-no: 0001213900-24-059058 (33 Act) Size: KB |
Jul-03-2024 | 241100430 |
UPLOAD | Document | Acc-no: 0000000000-24-007564 ( Act) Size: KB | Jul-02-2024 | |
F-3 | Document | Registration statement for specified transactions by certain foreign private issuers Acc-no: 0001213900-24-057313 (33 Act) Size: KB |
Jun-28-2024 | 241087042 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-054273 (34 Act) Size: KB |
Jun-20-2024 | 241056147 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-050097 (34 Act) Size: KB |
Jun-05-2024 | 241022825 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-043996 (34 Act) Size: KB |
May-16-2024 | 24953626 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-039900 (34 Act) Size: KB |
May-06-2024 | 24915635 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-038473 (34 Act) Size: KB |
May-01-2024 | 24902874 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-038160 (34 Act) Size: KB |
May-01-2024 | 24900285 |
424B5 | Document | Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001213900-24-037945 (33 Act) Size: KB |
Apr-30-2024 | 24898640 |
20-F | Document | Annual and transition report of foreign private issuers pursuant to sections 13 or 15(d) Acc-no: 0001213900-24-037806 (34 Act) Size: KB |
Apr-30-2024 | 24896991 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-021880 (34 Act) Size: KB |
Mar-12-2024 | 24743129 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-020488 (34 Act) Size: KB |
Mar-06-2024 | 24726855 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-014899 (34 Act) Size: KB |
Feb-16-2024 | 24648313 |
Recent 20 filings. View all MDxHealth SA filings
Very good communication and delivery made within the timeframe I was advised of
Thanks I look forward to using the product to improve my skin tone
young lad who new his job ansered questions and new what was best for me.
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by